CMMB · Chemomab Therapeutics Ltd. · Financials
Market Cap
$18.69M
Shares
7.33M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$9M
+35.5%
FY2025
Diluted EPS
$0.02
-53.8%
FY2025
Operating Cash Flow
-$11.13M
+27.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| $2.33M | $2.47M | $4.39M | $5.14M | $3.31M | — | — | — | — | — | |
| $5.83M | $11.33M | $18.38M | $16.98M | $6.33M | $4.68M | $13.3M | $7.51M | $6.23M | $2.38M | |
| $3.73M | $3.41M | $7.08M | $11.56M | $6.03M | $1.29M | $6.25M | $5.52M | $3.16M | $2.26M | |
| — | — | — | — | — | — | — | $66K | $51K | $41K | |
| — | — | — | — | — | $749K | $3.35M | — | — | — | |
| $9.57M | $14.74M | $25.46M | $28.53M | $12.37M | $5.97M | $22.9M | $13.04M | — | — | |
| -$112M | -$103M | — | — | — | — | — | -$13.04M | -$9.39M | -$4.64M | |
| — | — | — | — | — | — | — | $741K | $92K | $7000 | |
| $572K | $794K | $1.24M | $353K | -$111K | — | — | — | — | — | |
| -$9M | -$13.95M | -$24.22M | -$28.18M | -$12.48M | $5.95M | $27.12M | $13.49M | -$9.48M | -$4.61M | |
| $0 | $0 | $0 | -$534K | $0 | $0 | $0 | $306K | $323K | $137K | |
| -$9M | -$13.95M | -$24.22M | -$27.65M | -$12.48M | -$5.95M | -$27.12M | -$13.8M | -$9.81M | -$4.74M | |
| — | — | — | — | — | — | $27.12M | $13.38M | — | — | |
| USD/shares | $0.02 | $0.04 | $0.10 | $0.48 | $0.24 | — | — | — | — | — |
| USD/shares | $0.02 | $0.04 | $0.10 | $0.48 | $0.24 | — | — | — | — | — |
| shares | 510.23M | 359.05M | 235M | 56.9M | 51.87M | 34.19M | 538.2188 | 197.41K | — | — |
| shares | 510.23M | 359.05M | 235M | 56.9M | 51.87M | 34.19M | 538.2188 | 197.41K | — | — |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.